Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of QLS2319 in Healthy Subjects and Cancer Cachexia
Clinical trial NCT07735104 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07735104
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2028-10-30
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.